The current market price of Motilal Oswal S&P BSE Healthcare ETF is ₹51.02. ETF prices fluctuate during market hours based on demand, supply, and movements in the underlying index or assets.

Motilal Oswal S&P BSE Healthcare ETF managed by Motilal Oswal Asset Management Company Limited is ETF with a sector-specific investment objective to mirror BSE Healthcare TRI, subject to tracking error. The fund targets replication of the BSE Healthcare Total Return Index through a passive, index-linked approach aiming to capture total returns of constituents, emphasizing tracking the benchmark net of expenses. Holdings are concentrated in pharmaceuticals; top allocations include Sun Pharmaceutical Industries (13.2%), Divis Laboratories (6.0%) and Cipla (5.9%), with Pharmaceuticals & Biotechnology representing 75.6% and Healthcare Services 23.7% by weight. Performance shows 1Y: +10.3% and 3Y CAGR: +22.8%, reflecting concentrated sector exposure that has driven above-benchmark cyclical gains while aligning returns with the BSE Healthcare TRI mandate over measured periods. Operationally the ETF had AUM ₹40.2 Cr on Jan 2026 with average ₹39.5 Cr, expense ratio 0.2%, managed by Mr. Swapnil Mayekar (Jul 2022) and Mr. Dishant Mehta (Oct 2024).

Motilal Oswal S&P BSE Healthcare ETF is designed to track BSE Healthcare Total Return Index, allowing investors to gain exposure to its underlying securities through a single investment.

The expense ratio of Motilal Oswal S&P BSE Healthcare ETF is 0.23%. This represents the annual fee charged by the fund house for managing the ETF and is deducted from the fund’s assets.

The Assets Under Management (AUM) of Motilal Oswal S&P BSE Healthcare ETF is approximately ₹40.21. AUM reflects the total market value of assets managed by the ETF and is often used as an indicator of fund size and liquidity.

Motilal Oswal S&P BSE Healthcare ETF is classified under the as per the risk-o-meter defined by the fund house risk category. The risk level depends on the volatility of the underlying index, market conditions, and asset composition of the ETF.

The tracking error of Motilal Oswal S&P BSE Healthcare ETF is depends on how closely the ETF follows its benchmark. Tracking error measures how closely the ETF’s performance matches its benchmark index over time.

Motilal Oswal S&P BSE Healthcare ETF does not currently declare dividends and may reinvest earnings into the fund. Dividend treatment depends on the ETF structure and fund house policy.

Based on available data, Motilal Oswal S&P BSE Healthcare ETF has delivered the following returns: 1-year return: 13.13%. 3-year return: 81.57%. 5-year return: 121.06%. Past performance does not guarantee future results.

Before investing in Motilal Oswal S&P BSE Healthcare ETF, investors generally consider the underlying index, expense ratio, tracking error, risk profile, liquidity, and how the ETF fits within their overall portfolio strategy.